Wells Fargo lowered the firm’s price target on Bath & Body Works to $32 from $35 and keeps an Equal Weight rating on the shares. The firm is cautious into Q3 EPS, and is tapering its Q3 estimates and cutting Q4 numbers. The story continues to struggle to find a bottom, and following weak checks throughout Q3, Wells sees no catalyst for an inflection.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.